The Hope Difference

source url Hope-DifferenceTreating the whole person. Not only is it our mission, ita��s what drives us every day. At Hope Cancer Care of Nevada, our patients receive the latest state-of-the-art cancer treatment along with a personally tailored program designed to put the body, mind and spirit at ease as it heals.

http://caboclonharaue.com/?kreosan=op%C3%A7%C3%B5es-bin%C3%A1rias-como-ganhar&020=6c Our philosophy, which combines leading medical treatments with the ability to focus solely on their recovery. This approach allows our highly trained staff to craft individualized treatment programs for each patient.

http://melroth.com/?komp=operazioni-binarie-con-paypal&310=57 Patient dignity and respect is foremost at Hope Cancer Care of Nevada. We take great measures to exceed your expectations and to be there for you, and your family, every step of the way.

slide_0

Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized

05/22/18

binäre optionen und steuer The 2018 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline and cancer incidence dropped in men and remained stable in women. A companion study reports on recent changes in prostate … Read More


The Pendulum Swings (Back) on Prostate Cancer Screening

05/08/18

watch By David Sampson The U.S. Preventive Services Task Force (USPSTF) has updated its guideline for prostate cancer screening. The group now recommends that men ages 55 to 69 who are interested in screening talk to their doctors about potential benefits … Read More


U.S. Preventive Services Task Force Supports Informed Decision making for Prostate Cancer Screening

05/08/18

By David Sampson The U.S. Preventive Services Task Force (USPSTF) has updated its recommendations for prostate cancer screening, now recommending that men 55 to 69 who are interested in screening talk to their doctors about potential benefits and harms of … Read More


NCI study revises molecular classification for most common type of lymphoma

04/11/18

In a study in The New England Journal of Medicine, NCI researchers identified genetic subtypes of diffuse large B-cell lymphoma (DLBCL), the most common type of lymphoma, that could help explain why some patients with the disease respond to treatment … Read More


NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas

03/28/18

Interim results from a clinical trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF) show that the drug sorafenib tosylate (Nexavar) extended progression-free survival compared with a placebo. …read more Source:: Cancer


Highly Processed Foods & Cancer Risk

02/15/18

By David Sampson A study out Wednesday suggests eating a lot of highly processed foods might be associated with higher rates of cancer. The study appears in BMJ, and the authors admit more study is needed, but warn that the … Read More


Rodents and Radiation: What to Take Away from New Study Findings

02/02/18

By David Sampson Preliminary data was released today from two rodent studies by the National Toxicology Program (NTP), to explore potential links between cell phones and cancer. The studies have found high exposure to radiofrequency radiation (RFR) resulted in tumors … Read More


Detecting cancer with a blood test: New study shows promise, but caution remains

01/19/18

By David Sampson A study published this week in Science reports promising results of a blood test designed to detect eight common cancer types by measuring circulating proteins and mutations in cell-free DNA. The study comes from the Johns Hopkins … Read More


Study links inflammation-causing foods to higher risk of colorectal cancer

01/18/18

By David Sampson A study in today’s JAMA Oncology links diets that include foods that can cause inflammation to an increased risk of colorectal cancer. Those foods include meats, refined grains, and high-calorie beverages. We asked Marji McCullough, SCD, RD, … Read More


Norman Sharpless sworn in as director of the National Cancer Institute

10/18/17

Norman E. a�?Neda�? Sharpless, M.D., becomes the 15th director of the National Cancer Institute (NCI). He comes to NCI from the University of North Carolina School of Medicine, where he was director of the Lineberger Comprehensive Cancer Center. …read more … Read More